This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles,
Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for …

Nanotechnology has been developed rapidly in recent decades and widely applied in
ocular disease therapy. Nano-drug delivery systems overcome the bottlenecks of current …

Autoimmune uveitis is a major cause of vision loss and glucocorticoids are major traditional
medications, which may induce serious complications. Rapamycin has been demonstrated …

Chronic ocular diseases can seriously impact the eyes and could potentially result in
blindness or serious vision loss. According to the most recent data from the WHO, there are …

Damage to the retinal pigment epithelium, Bruch's membrane and/or tissues underlying
macula is known to increase the risk of age-related macular degeneration (AMD). AMD is …

Non-invasive drug delivery offers a safe treatment while improving patient compliance.
However, due to the particular physiological structure of the ocular, long-term retention and …

Cytomegalovirus (CMV) retinitis is a vision-threatening disease that principally afflicts
immunosuppressed patients. For the management of the disease, Ganciclovir (GCV) is …

The invigoration of protein and peptides in serious eye disease includes age-related
macular degeneration, choroidal neovascularization, retinal neovascularization, and …

Eye diseases are associated with visual impairment, reduced quality of life, and may even
lead to vision loss. The efficacy of available treatment of eye diseases is not satisfactory. The …

Age-related macular degeneration (AMD) is a significant factor contributing to serious vision
loss in adults above 50. The presence of posterior segment barriers serves as chief …